Log in to save to my catalogue

CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6071917

CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

About this item

Full title

CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

Publisher

London: Nature Publishing Group UK

Journal title

Nature (London), 2018-07, Vol.559 (7713), p.285-289

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

The observation that BRCA1
-
and BRCA2-deficient cells are sensitive to inhibitors of poly(ADP–ribose) polymerase (PARP) has spurred the development of cancer therapies that use these inhibitors to target deficiencies in homologous recombination
1
. The cytotoxicity of PARP inhibitors depends on PARP trapping, the formation of non-coval...

Alternative Titles

Full title

CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6071917

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6071917

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-018-0291-z

How to access this item